208 related articles for article (PubMed ID: 104070)
1. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
[No Abstract] [Full Text] [Related]
2. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
[No Abstract] [Full Text] [Related]
3. [GERL-coated vesicle system in the melanin synthesizing cell: its three-dimensional ultrastructure and tyrosinase activity (author's transl)].
Ogura H; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(13):883-901. PubMed ID: 413959
[No Abstract] [Full Text] [Related]
4. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
Tomita Y; Moro S; Seiji M
J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
[No Abstract] [Full Text] [Related]
5. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis.
Menon IA; Haberman HF
Acta Derm Venereol; 1978; 58(1):9-11. PubMed ID: 75646
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
Kageshita T; Ono T; Arao T; Tomita Y
Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
[No Abstract] [Full Text] [Related]
7. [Mouse model of tyrosinase positive type oculocutaneous albinism (chinchilla mouse, Cch/Cch) : tyrosinase activity and ultrastructure of hair bulb melanocyte (author's transl)].
Hori Y; Shichiro M; Mizoguchi M
Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):987-94. PubMed ID: 6780712
[No Abstract] [Full Text] [Related]
8. [Melanocyte and melanin (author's transl)].
Oikawa A
Seikagaku; 1976 Sep; 48(9):872-8. PubMed ID: 825596
[No Abstract] [Full Text] [Related]
9. [Chemico-clinical aspects of tyrosinase (author's transl)].
Pavel S; Matous B
Cesk Dermatol; 1976 Dec; 51(6):413-9. PubMed ID: 827337
[No Abstract] [Full Text] [Related]
10. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
Mojamdar M; Imokawa G; Mishima Y
J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
[No Abstract] [Full Text] [Related]
11. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
Blagoeva PM
Neoplasma; 1977; 24(3):291-4. PubMed ID: 408715
[TBL] [Abstract][Full Text] [Related]
12. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
Imokawa G; Mishima Y
Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
[TBL] [Abstract][Full Text] [Related]
13. A modified method for the isolation of melanosomes from B16 melanoma.
Haberman HF; Menon IA
J Invest Dermatol; 1973 Feb; 60(2):67-72. PubMed ID: 4348133
[No Abstract] [Full Text] [Related]
14. Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium.
Dryja TP; O'Neil-Dryja M; Pawelek JM; Albert DM
Invest Ophthalmol Vis Sci; 1978 Jun; 17(6):511-4. PubMed ID: 96039
[TBL] [Abstract][Full Text] [Related]
15. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
Yamamoto H; Takeuchi T
J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
[TBL] [Abstract][Full Text] [Related]
16. Biochemistry of melanin synthesis: in vivo effects of MSH on tyrosinase and melanogenesis of pigmentary system.
Lee TH; Lee MS
Yale J Biol Med; 1973 Dec; 46(5):493-9. PubMed ID: 4205116
[No Abstract] [Full Text] [Related]
17. Histochemical evidence that peroxidase does not affect melanin formation in feather melanocytes.
Brumbaugh J; Bowers R; Lee K
Yale J Biol Med; 1973 Dec; 46(5):523-34. PubMed ID: 4205119
[No Abstract] [Full Text] [Related]
18. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
Jimbow K; Jimbow M; Chiba M
J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
[TBL] [Abstract][Full Text] [Related]
19. [Malignant melanoma--a PO-cell tumor? (author's transl)].
Schmidt H; Stintz AR
Arch Geschwulstforsch; 1975; 45(2):146-52. PubMed ID: 812451
[TBL] [Abstract][Full Text] [Related]
20. Melanization and tyrosinase activity.
Seiji M; Miyazaki K
J Invest Dermatol; 1971 Nov; 57(5):316-22. PubMed ID: 5001257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
